All Biotech Act articles
-
Industry newsThe HMA-EMA’s NDSG publishes observatory report on AI in medicines development
Industry is bringing artificial intelligence to EU medicines regulators faster than ever before. The number of new AI applications discussed with applicants as part of regulatory procedures has risen sharply, reflecting how quickly the technology is being adopted across the development and evaluation of medicines.